Lataa...
Beta-blockers in cirrhosis: Evidence-based indications and limitations
Non-selective beta-blockers (NSBBs) are the mainstay of treatment for portal hypertension in the setting of liver cirrhosis. Randomised controlled trials demonstrated their efficacy in preventing initial variceal bleeding and subsequent rebleeding. Recent evidence indicates that NSBBs could prevent...
Tallennettuna:
| Julkaisussa: | JHEP Rep |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7005550/ https://ncbi.nlm.nih.gov/pubmed/32039404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2019.12.001 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|